| BSE: 524764 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE230G01020 |
| BSE 00:00 | 22 Jun | 29.05 |
-0.35 (-1.19%) |
OPEN
29.85 |
HIGH
30.90 |
LOW
27.50 |
| NSE 05:30 | 01 Jan | Nutraplus India Ltd |
| OPEN | 29.85 |
| PREVIOUS CLOSE | 29.40 |
| VOLUME | 59176 |
| 52-Week high | 51.05 |
| 52-Week low | 22.80 |
| P/E | 726.25 |
| Mkt Cap.(Rs cr) | 99 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Nutraplus Products (India) Limited was originally incorporated as a private limited company on 6 Feb.'90. It was subsequently converted into a public limited company with effect from 13 Jun.'92. The company implemented a project for the manufacture of veterinary bulk drugs namely dimentridazole (DMZ) and dinitolmide (DOT) at Tarapur, Maharashtra. Initially, the company set up manufacturing fac...> More
| COMPANY INFORMATION | |||||||
| Chairman & Managing Director : | Mukesh D Naik | ||||||
| Independent Director : | Mukesh R Desai | ||||||
| Whole-time Director : | Dilip K Pimple | ||||||
| Independent Director : | Pramesh Kumar B Mehta | ||||||
| Director : | Nidhi M Naik | ||||||
| Independent Director : | Vinod Laxman Parab | ||||||
| AUDITOR : | AMPAC & Associates/Raman S Shah & Associates | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| Plot No N-92, MIDC-Tarapur Boisar,Thane,Maharashtra-401506 | |||||||
| Ph : | |||||||
| WEBSITE : http://www.nutraplusindia.com | |||||||
| E-mail : nutraplus@gmail.com | |||||||
